Repositioning Candidate Details

Candidate ID: R1477
Source ID: DB13153
Source Type: approved; experimental
Compound Type: small molecule
Compound Name: Levomenol
Synonyms: (-)-alpha-Bisabolol; alpha-(-)-bisabolol; alpha-bisabolol; Bisabolol; Kamillosan; Levomenol; α-(−)-bisabolol
Molecular Formula: C15H26O
SMILES: [H][C@@]1(CCC(C)=CC1)[C@@](C)(O)CCC=C(C)C
Structure:
DrugBank Description: Bisabolol, or more formally α-(−)-bisabolol or also known as levomenol, (-)-alpha-Bisabolol is found in fats and oils. (-)-alpha-Bisabolol is isolated from essential oil of Matricaria chamomilla (German chamomile) (-)-alpha-Bisabolol belongs to the family of Sesquiterpenes. These are terpenes with three consecutive isoprene units.
CAS Number: 23089-26-1
Molecular Weight: 222.372
DrugBank Indication: Levomenol has been known to elicit a number of potentially beneficial pharmacological effects, including anti-irritant, anti-inflammatory, and anti-microbial actions. Bisabolol is also demonstrated to enhance the percutaneous absorption of certain molecules
DrugBank Pharmacology: Levomenol is an anti-inflammatory and natural moisturizing agent that has been found to diminish the signs of photodamage, reduce pruritus, and ameliorate skin texture and elasticity.
DrugBank MoA: --
Targets: --
Inclusion Criteria: Therapeutic strategy associated